---
permalink: /patents/
title: "Patents"
author_profile: true
redirect_from: 
  - /md/
  - /markdown.html
---
<style>
    /* Add custom styling for the scroll to top button */
    #scrollToTopBtn {
      display: none !important;
      position: fixed !important;
      bottom: 20px !important;
      right: 20px !important;
      z-index: 99 !important; 
    }


/* Your custom CSS styles go here */
.btn-outline-custom {
  color: #2C91F5 !important; /* Text color */
  border: 1px solid #000000 !important; 
  border-color: #2C91F5 !important; /* Border color */
  background-color: #ffffff !important;
}
.btn-outline-custom:hover{
  color: #ffffff !important; /* Text color on hover */
  background-color: #2C91F5 !important; /* Background color on hover */
  border-color: #2C91F5 !important; /* Border color on hover */
}

</style>

<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold; font-size: 18px;" >CRISPR-PE System For Retinol Dehydrogenase 12 (Rdh12) Gene Mutations For Use In The Treatment
Of Retinitis Pigmentosa (RP) Disease - TR/EU, pending, No: TR2021022284A2 / WO2023129095A1</p> 

<p><a href="https://worldwide.espacenet.com/patent/search/family/085117228/publication/WO2023129095A1?q=WO2023129095A1" class="btn btn-outline-primary btn-outline-custom" style="text-decoration: none;">ACCESS DETAILS</a></p>
---

<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold; font-size: 18px;" >Xeno Nucleic Acid Antisense-Oligonucleotide (XNA-ASO) Sequences for the Genetic Treatment of USH2A Induced Retinitis Pigmentosa Disease - 
TR/EU, pending, No: TR2022001648A2 / WO2023154026A1</p> 

<p><a href="https://worldwide.espacenet.com/patent/search/family/085117987/publication/WO2023154026A1?q=WO2023154026A1" class="btn btn-outline-primary btn-outline-custom" style="text-decoration: none;">ACCESS DETAILS</a></p>
---
<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold; font-size: 18px;" >Neural Lentiviral Vector Containing The Functional Abca4 Gene For Use In The Treatment Of Retinitis
Pigmentosa (RP) Disease -  TR, pending, No: TR2022000448A2</p> 

<p><a href="https://worldwide.espacenet.com/patent/search/family/085117719/publication/TR2022000448A2?q=pn%3DTR2022000448A2" class="btn btn-outline-primary btn-outline-custom" style="text-decoration: none;">ACCESS DETAILS</a></p>

---
<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold; font-size: 18px;" >Neurotrophic Factor And Optogenetic System-Based Lentiviral System For Use In Retinal Diseases - TR,
pending, No: TR2022021763A2 </p> 

---
<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold; font-size: 18px;" >Methods for the Treatment of Spinal Muscular Atrophy - TR, pending, No: 2021/018884</p> 

